China’s Molecular Diagnostics Market Growing 22% Annually
This article was originally published in PharmAsia News
Executive Summary
Molecular diagnostics has become the fastest growing segment of China’s vitro diagnostics market, an industry contributing 80% of clinical diagnostic information and around 20% of total revenues.